Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ron Martell Insider Profile
4 Followers
Ron Martell, CEO, Director at Eloxx Pharmaceuticals, holds 0.00 shares in Eloxx Pharmaceuticals (Ticker: ELOX), holds ― shares in Plus Therapeutics (Ticker: PSTV), holds 331.19K shares in Jasper Therapeutics (Ticker: JSPR). Most recently, Ron Martell ― shares of Eloxx Pharmaceuticals on ― for an estimated value of ―.
Ron Martell has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ron Martell holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 26, 2010 - Mar 26, 2011
Return:-62.90%
The most profitable trade made by Ron Martell
Ron Martell's Trading History
Eloxx Pharmaceuticals
―
CEO, Director
―
$0.00
Plus Therapeutics
―
Director
―
―
Jasper Therapeutics
Oct 13, 2023
Pres, CEO & Dir, Director
Uninformative Sell
74.40K
$2.01M
Humanigen
―
―
―
$0.00
Neurogesx
Jan 03, 2013
―
Uninformative Buy
―
$125.00
Poniard Pharmaceuticals
Oct 07, 2011
Chief Executive Officer, Director
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Ron Martell's performance on stock
You May Also Like
Ron Martell insider profile FAQ
What is the percentage of profitable transactions made by Ron Martell?
The percentage of profitable transactions made by Ron Martell is ―.
What is the average return per transaction made by Ron Martell?
The average return per transaction made by Ron Martell is ―.
What stocks does Ron Martell hold?
Ron Martell holds: ELOX, PSTV, JSPR, HGENQ, NGSX, PARD stocks.
What was Ron Martell’s latest transaction?
Ron Martell latest transaction was an Uninformative Buy of ―.
What was Ron Martell's most profitable transaction?
Ron Martell’s most profitable transaction was an Informative Buy of PARD stock on March 26, 2010. The return on the trade was -62.90%.
What is Ron Martell's role in Eloxx Pharmaceuticals?
Ron Martell's role in Eloxx Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.